Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Ormond Beach › NPI 1851940035
Hospital

Florida Hospital Waterman INC

Florida Hospital Waterman INC was paid $16.53M by Medicaid between Jan 2018 and Dec 2024, across 227 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.

33Billing provider infoFLORIDA HOSPITAL WATERMAN INC
ORMOND BEACH, FL 32174
33aNPI1851940035assigned 09/10/2019
33bProvider typeRehabilitation Hospital Unit
28Total paid$16.53M
24GClaims636,306
24DCodes billed227
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Rehabilitation Hospital Unit providers in Florida

Rank by total paid#5 of 11
Median peer was paid$15.92M
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201849,277$606K
2019124,554$2.35M
202097,300$2.10M
2021122,517$3.25M
2022129,659$3.77M
202378,596$3.04M
2024incomplete34,403$1.42M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 23% 42,583 37,960 $3.86M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 19% 33,011 28,142 $3.09M
96361 Intravenous infusion, hydration; each additional hour 8.6% 13,921 11,558 $1.42M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 8.0% 17,937 15,033 $1.32M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.4% 4,708 4,031 $729K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 3.6% 7,693 6,498 $596K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2.6% 3,331 2,892 $425K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.6% 5,729 5,139 $423K
70450 Computed tomography, head or brain; without contrast material 2.3% 4,607 3,801 $378K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.7% 5,945 3,709 $286K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.3% 4,361 3,649 $218K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.3% 1,824 1,495 $215K
215 more codes
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.3% 18,059 $215K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.1% 3,742 $175K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.0% 4,943 $167K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 2,850 $146K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 3,714 $137K
80053 Comprehensive metabolic panel <1% 38,853 $129K
71275 Computed tomographic angiography, chest, with contrast material <1% 872 $128K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 5,188 $117K
71046 Radiologic examination, chest; 2 views <1% 5,271 $100K
96375 Therapeutic injection; each additional sequential IV push <1% 13,384 $100K
0225U <1% 3,216 $87K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 284 $85K
81001 <1% 22,627 $82K
81025 <1% 17,695 $81K
87420 <1% 853 $80K
72125 Computed tomography, cervical spine; without contrast material <1% 1,288 $74K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 5,501 $65K
84484 <1% 13,034 $60K
71045 Radiologic examination, chest; single view <1% 14,412 $58K
87086 Culture, bacterial; quantitative colony count, urine <1% 10,753 $55K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,997 $54K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 5,399 $51K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,991 $51K
80048 Basic metabolic panel (calcium, ionized) <1% 7,056 $51K
81003 <1% 8,032 $50K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 677 $50K
59025 Fetal non-stress test <1% 1,533 $48K
82947 <1% 7,105 $43K
96376 <1% 3,444 $41K
73610 <1% 1,106 $37K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 979 $37K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 656 $36K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 611 $35K
76819 Fetal biophysical profile; without non-stress testing <1% 542 $34K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 44,043 $32K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 19,891 $30K
73630 <1% 1,458 $28K
84702 <1% 3,152 $26K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 607 $25K
73130 <1% 939 $25K
G0378 Hospital observation service, per hour <1% 5,183 $24K
73110 <1% 762 $22K
87070 <1% 979 $20K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 474 $20K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,050 $18K
73564 <1% 738 $17K
97161 <1% 182 $16K
J7030 Infusion, normal saline solution , 1000 cc <1% 15,289 $16K
76801 <1% 1,211 $16K
83880 <1% 1,956 $16K
72100 <1% 951 $15K
77067 Screening mammography, bilateral, including computer-aided detection <1% 516 $15K
92587 <1% 360 $14K
85610 <1% 9,674 $13K
86900 <1% 2,505 $13K
73030 <1% 864 $13K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 386 $12K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 10,721 $11K
76830 Ultrasound, transvaginal <1% 899 $10K
80051 <1% 802 $10K
93971 <1% 589 $10K
80061 Lipid panel <1% 2,049 $10K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 130 $9K
86901 <1% 2,502 $9K
86850 <1% 1,133 $9K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,439 $9K
01999 <1% 1,239 $8K
74022 <1% 850 $8K
36415 Collection of venous blood by venipuncture <1% 6,848 $8K
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,422 $8K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 7,763 $7K
85730 <1% 6,272 $7K
83735 <1% 6,663 $7K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,636 $7K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,460 $7K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 168 $7K
73080 <1% 243 $6K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 58 $6K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 715 $6K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 235 $6K
74018 <1% 212 $6K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 4,022 $6K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,573 $6K
87186 <1% 3,279 $5K
85027 <1% 2,777 $5K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 133 $5K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,568 $5K
84443 Thyroid stimulating hormone (TSH) <1% 2,256 $5K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,964 $4K
99213 Doctor's office visit, returning patient (routine) <1% 92 $4K
J2270 Injection, morphine sulfate, up to 10 mg <1% 5,685 $4K
71250 <1% 161 $4K
70551 Magnetic resonance imaging, brain; without contrast material <1% 14 $4K
83605 <1% 2,558 $4K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,349 $4K
70491 <1% 14 $4K
J2704 Injection, propofol, 10 mg <1% 689 $4K
76775 <1% 110 $4K
83690 <1% 9,832 $4K
73502 <1% 224 $3K
73590 <1% 167 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,484 $3K
83036 Hemoglobin; glycosylated (A1C) <1% 2,052 $3K
73090 <1% 141 $3K
84132 <1% 252 $3K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 308 $3K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 46 $3K
73562 <1% 265 $3K
82565 <1% 2,587 $3K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 63 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,091 $2K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 24 $2K
87040 <1% 2,091 $2K
84703 <1% 1,987 $2K
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg <1% 445 $2K
87077 <1% 2,473 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,604 $2K
80050 General health panel <1% 189 $2K
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 273 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,660 $2K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 92 $2K
12001 <1% 103 $1K
J7050 Infusion, normal saline solution, 250 cc <1% 1,917 $1K
82805 <1% 45 $1K
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 228 $1K
74019 <1% 29 $1K
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program <1% 507 $1K
77063 Screening digital breast tomosynthesis, bilateral <1% 250 $1K
87210 <1% 2,457 $1K
94761 <1% 669 $1K
86920 <1% 24 $998.54
J2060 Injection, lorazepam, 2 mg <1% 1,082 $991.04
86140 <1% 1,443 $894.90
J3475 Injection, magnesium sulfate, per 500 mg <1% 372 $854.71
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 315 $804.41
92650 <1% 33 $799.39
97162 <1% 26 $773.09
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 50 $716.80
73140 <1% 43 $600.23
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 148 $598.01
85379 <1% 1,066 $589.16
97163 <1% 16 $562.40
87899 <1% 20 $508.64
78815 Positron emission tomography (PET) for limited area imaging <1% 14 $459.03
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 761 $436.86
36430 <1% 23 $402.94
80047 <1% 642 $390.57
76642 <1% 14 $382.06
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 124 $345.97
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,487 $336.73
85014 <1% 2,178 $330.53
84439 <1% 568 $314.43
J1650 Injection, enoxaparin sodium, 10 mg <1% 243 $298.49
99152 <1% 94 $298.49
82550 <1% 412 $289.65
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 42 $262.65
82077 <1% 646 $252.82
12011 <1% 29 $245.73
97116 <1% 68 $238.91
82607 <1% 167 $232.68
94644 <1% 15 $221.70
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 473 $217.62
84520 <1% 1,088 $213.63
72070 <1% 39 $210.76
76870 <1% 13 $206.13
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 18 $184.39
84100 <1% 86 $172.88
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 75 $160.76
87081 <1% 1,658 $155.08
72131 <1% 31 $153.72
87641 <1% 55 $138.84
85652 <1% 732 $137.33
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 794 $102.68
72040 <1% 79 $101.28
85018 <1% 603 $77.55
90715 <1% 281 $77.31
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 59 $57.03
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 30 $50.88
0002A <1% 18 $40.00
73552 <1% 29 $37.87
80076 <1% 17 $34.60
82553 <1% 129 $30.97
87486 <1% 481 $19.41
0001A <1% 18 $16.94
82746 <1% 12 $16.13
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 42 $15.69
87158 <1% 124 $6.88
J0780 Injection, prochlorperazine, up to 10 mg <1% 44 $6.36
87205 <1% 92 $2.28
82374 <1% 98 $1.02
84295 <1% 112 $1.02
82435 <1% 98 $1.02
84550 0% 17 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 57 $0.00
80143 0% 73 $0.00
80179 0% 110 $0.00
10060 0% 12 $0.00
P9016 Red blood cells, leukocytes reduced, each unit 0% 16 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 57 $0.00
J7510 Prednisolone oral, per 5 mg 0% 48 $0.00
82010 0% 40 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 0% 14 $0.00
87045 0% 14 $0.00
84145 0% 112 $0.00
29125 0% 12 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 16 $0.00
83615 0% 27 $0.00
C1769 Guide wire 0% 131 $0.00
87581 0% 457 $0.00
86592 0% 15 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 40 $0.00
88304 0% 20 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 42 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 15 $0.00
J1815 Injection, insulin, per 5 units 0% 34 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKORCHUK, ANDRII (CFO)
Parent organizationFLORIDA HOSPITAL WATERMAN INC